Skip to main content
Erschienen in: Pediatric Surgery International 3/2013

01.03.2013 | Original Article

Primary hyperparathyroidism in adolescents: the same but different

verfasst von: Itai Pashtan, Raymon H. Grogan, Sharone P. Kaplan, Karen Devon, Peter Angelos, Donald Liu, Edwin L. Kaplan

Erschienen in: Pediatric Surgery International | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Primary hyperparathyroidism has been studied more extensively in adults than in adolescents. The objective of this study is to define the similarities and differences that exist between these groups.

Methods

A retrospective review of 1,000 primary hyperparathyroidism patients undergoing parathyroidectomy at a single tertiary-care university teaching hospital between 1990 and 2004. All patients 20 years of age or younger comprised our study cohort, and were compared to two historical adult groups.

Results

Of 1,000 parathyroidectomies, 21 (2.1 %) were 20 years of age or younger (adolescent). The adolescents presented with higher serum calcium levels (p < 0.01) more severe symptoms (p = 0.02), more renal stones (p = 0.048), and a higher incidence of hypercalcemic crisis (p = 0.02), when compared with adults. We found that 67 % suffered from a triad of tiredness, weakness, and depression versus 39 % of adults (p = 0.02). Sestamibi scans were less helpful in the adolescents than in adults. Similar to the adults, 86 % of adolescent patients had single gland disease, and 95 % were cured at the first operation.

Conclusion

Adolescents with primary hyperparathyroidism typically have more severe disease than adults. Contrary to popular belief, most adolescents have single gland disease and not hyperplasia associated with a genetic disorder.
Literatur
1.
Zurück zum Zitat Salti GI, Fedorak I, Yashiro T, Fulton N, Hara H, Yousefzadeh D, Kaplan EL (1992) Continuing evolution in the operative management of primary hyperparathyroidism. Arch Surg 127:831–836 (discussion 836–837)PubMedCrossRef Salti GI, Fedorak I, Yashiro T, Fulton N, Hara H, Yousefzadeh D, Kaplan EL (1992) Continuing evolution in the operative management of primary hyperparathyroidism. Arch Surg 127:831–836 (discussion 836–837)PubMedCrossRef
2.
Zurück zum Zitat Miller BS, Dimick J, Wainess R, Burney RE (2008) Age- and sex-related incidence of surgically treated primary hyperparathyroidism. World J Surg 32:795–799PubMedCrossRef Miller BS, Dimick J, Wainess R, Burney RE (2008) Age- and sex-related incidence of surgically treated primary hyperparathyroidism. World J Surg 32:795–799PubMedCrossRef
3.
Zurück zum Zitat Loh KC, Duh QY, Shoback D, Gee L, Siperstein A, Clark OH (1998) Clinical profile of primary hyperparathyroidism in adolescents and young adults. Clin Endocrinol (Oxf) 48:435–443CrossRef Loh KC, Duh QY, Shoback D, Gee L, Siperstein A, Clark OH (1998) Clinical profile of primary hyperparathyroidism in adolescents and young adults. Clin Endocrinol (Oxf) 48:435–443CrossRef
4.
Zurück zum Zitat Harman CR, van Heerden JA, Farley DR, Grant CS, Thompson GB, Curlee K (1999) Sporadic primary hyperparathyroidism in young patients: a separate disease entity? Arch Surg 134:651–655 (discussion 655–656)PubMedCrossRef Harman CR, van Heerden JA, Farley DR, Grant CS, Thompson GB, Curlee K (1999) Sporadic primary hyperparathyroidism in young patients: a separate disease entity? Arch Surg 134:651–655 (discussion 655–656)PubMedCrossRef
5.
Zurück zum Zitat Hsu SC, Levine MA (2002) Primary hyperparathyroidism in children and adolescents: the Johns Hopkins Children’s Center experience 1984–2001. J Bone Miner Res 17(Suppl 2):N44–N50PubMed Hsu SC, Levine MA (2002) Primary hyperparathyroidism in children and adolescents: the Johns Hopkins Children’s Center experience 1984–2001. J Bone Miner Res 17(Suppl 2):N44–N50PubMed
6.
Zurück zum Zitat Joshua B, Feinmesser R, Ulanovski D, Gilat H, Sulkes J, Eshed V, Shpitzer T (2004) Primary hyperparathyroidism in young adults. Otolaryngol Head Neck Surg 131:628–632PubMedCrossRef Joshua B, Feinmesser R, Ulanovski D, Gilat H, Sulkes J, Eshed V, Shpitzer T (2004) Primary hyperparathyroidism in young adults. Otolaryngol Head Neck Surg 131:628–632PubMedCrossRef
7.
Zurück zum Zitat Sneider MS, Solorzano CC, Montano RE, Anello C, Irvin GL, Lew JI (2009) Sporadic primary hyperparathyroidism in young individuals: different disease and treatment? J Surg Res 155:100–103PubMedCrossRef Sneider MS, Solorzano CC, Montano RE, Anello C, Irvin GL, Lew JI (2009) Sporadic primary hyperparathyroidism in young individuals: different disease and treatment? J Surg Res 155:100–103PubMedCrossRef
8.
Zurück zum Zitat Jaskowiak NT, Sugg SL, Helke J, Koka MR, Kaplan EL (2002) Pitfalls of intraoperative quick parathyroid hormone monitoring and gamma probe localization in surgery for primary hyperparathyroidism. Arch Surg 137:659–668 (discussion 668–669)PubMedCrossRef Jaskowiak NT, Sugg SL, Helke J, Koka MR, Kaplan EL (2002) Pitfalls of intraoperative quick parathyroid hormone monitoring and gamma probe localization in surgery for primary hyperparathyroidism. Arch Surg 137:659–668 (discussion 668–669)PubMedCrossRef
9.
Zurück zum Zitat Aparicio López C, Anton-Martin P, Gil-Fournier B, Ramiro-León S, Pérez-Nanclares G, Pérez de Nanclares G, Martínez Menéndez B, Castaño L (2012) Familial hypocalciuric hypercalcemia: new mutation in the CASR gene converting valine 697 to methionine. Eur J Pediatr 171:147–150PubMedCrossRef Aparicio López C, Anton-Martin P, Gil-Fournier B, Ramiro-León S, Pérez-Nanclares G, Pérez de Nanclares G, Martínez Menéndez B, Castaño L (2012) Familial hypocalciuric hypercalcemia: new mutation in the CASR gene converting valine 697 to methionine. Eur J Pediatr 171:147–150PubMedCrossRef
10.
Zurück zum Zitat Krubsack AJ, Wilson SD, Lawson TL, Kneeland JB, Thorsen MK, Collier BD, Hellman RS, Isitman AT (1989) Prospective comparison of radionuclide, computed tomographic, sonographic, and magnetic resonance localization of parathyroid tumors. Surgery 106:639–644 (discussion 644–646)PubMed Krubsack AJ, Wilson SD, Lawson TL, Kneeland JB, Thorsen MK, Collier BD, Hellman RS, Isitman AT (1989) Prospective comparison of radionuclide, computed tomographic, sonographic, and magnetic resonance localization of parathyroid tumors. Surgery 106:639–644 (discussion 644–646)PubMed
11.
Zurück zum Zitat Melloul M, Paz A, Koren R, Cytron S, Feinmesser R, Gal R (2001) 99mTc-MIBI scintigraphy of parathyroid adenomas and its relation to tumour size and oxyphil cell abundance. Eur J Nucl Med 28:209–213PubMedCrossRef Melloul M, Paz A, Koren R, Cytron S, Feinmesser R, Gal R (2001) 99mTc-MIBI scintigraphy of parathyroid adenomas and its relation to tumour size and oxyphil cell abundance. Eur J Nucl Med 28:209–213PubMedCrossRef
12.
Zurück zum Zitat Saxe AW, Gibson GW, Russo IH, Gimotty P (1992) Measurement of estrogen and progesterone receptors in abnormal human parathyroid tissue. Calcif Tissue Int 51:344–347PubMedCrossRef Saxe AW, Gibson GW, Russo IH, Gimotty P (1992) Measurement of estrogen and progesterone receptors in abnormal human parathyroid tissue. Calcif Tissue Int 51:344–347PubMedCrossRef
Metadaten
Titel
Primary hyperparathyroidism in adolescents: the same but different
verfasst von
Itai Pashtan
Raymon H. Grogan
Sharone P. Kaplan
Karen Devon
Peter Angelos
Donald Liu
Edwin L. Kaplan
Publikationsdatum
01.03.2013
Verlag
Springer-Verlag
Erschienen in
Pediatric Surgery International / Ausgabe 3/2013
Print ISSN: 0179-0358
Elektronische ISSN: 1437-9813
DOI
https://doi.org/10.1007/s00383-012-3222-3

Weitere Artikel der Ausgabe 3/2013

Pediatric Surgery International 3/2013 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.